{"disease":{"id":"severe-major-depression","name":"severe major depression"},"drugs":{"marketed":[{"drug_id":"doxepin","indication_name":"Severe major depression with psychotic features","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zonalon","generic_name":"DOXEPIN","company_name":"","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"Tricyclic Antidepressant","quality_score":80,"revenue":null,"mechanism":"Zonalon works by blocking histamine H1 receptors in the brain, which helps to reduce anxiety and itching, and improve mood."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03360695","title":"Bridge: Proactive Psychiatry Consultation and Case Management for Patients With Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":185,"lead_sponsor_name":"Massachusetts General Hospital","has_results":true},{"nct_id":"NCT07590609","title":"Effect of XingpiJieyu Formula on Mitochondrial Energy Metabolism in Severe Liver-Stagnation and Spleen-Deficiency Depression.","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Peking University Sixth Hospital","has_results":false},{"nct_id":"NCT05837598","title":"Adapting the Tumor Board Model for Mental Illness and Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT07503002","title":"Shortened LSD Intervention for Major Depressive Disorder","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":10,"lead_sponsor_name":"Johns Hopkins University","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}